SOPHiA GenetIcs to raise capital via ordinary-share offering
SOPHiA GENETICS announced a proposed underwritten public offering of its ordinary shares, with an option for underwriters to buy up to 15% more. The deal size and timing depend on market conditions, and there is no assurance of completion. The move could dilute existing shareholders in the near term but may fund growth initiatives in AI-driven precision medicine.
View signal analysis